Zinc p-phenolsulfonate*, benzalkonium chloride solution*, purified water, ethanol, methylphenylpolysiloxane, l-menthol, hydroxypropyl--cyclodextrin, polyethylene glycol 1500, polyoxyethylene-methylpolysiloxane copolymer, sodium lactate solution, lactic acid, polyoxyethylene polyoxypropylene decyl tetradecyl ether, edetate trisodium, calcium alginate, 1,3-butylene glycol, l-menthyl lactate, lily extract, lavender extract (1), fragrance * indicates active ingredient
In a double-blind study of n=16 chronic insomniac patients, intravenous DSIP at 25 nmol/kg over 3 nights was associated with higher sleep efficiency and shorter sleep latency (the time it takes to fall asleep) compared with placebo, but the effects were described as weak [4]
Bhoyar Institute of Pharmaceutical Education and Research, Wardha, Maharashtra, 442001, India Correspondence: Muhammad Afzal, Email [email protected] Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder indicated by hyperglycemia
Side effects include stomach issues, skin rashes, and allergic responses
INHALTSSTOFFE ZUTATEN Wirkstoff je 1 ml Injektionslsung ( 1 Ampulle)i1.000 Mikrogramm (1 mg) Cyanocobalamin.Die sonstigen Bestandteile sind: Natriumdihydrogenphosphat-Dihydrat, Natriumchlorid, Wasser fr Injektionszwecke, Natriumhydroxid zur pH-Wert-Einstellung
